Alicia Henn

Alicia Henn is a dedicated figure in the field of Biomedical Science, striving to bring about positive and lasting changes in how this field is practiced globally.

She is the founder and owner of the In Vitro Reproducibility group on LinkedIn, where discussions about improving the accessibility of new therapeutics for patients in need take place.

Alicia Henn's educational background includes studies at Monroe High School in Rochester, NY, Writers and Books in Rochester, NY, an Executive MBA focused on Health Markets and Entrepreneurship from the University of Rochester - William E. Simon Graduate School of Business Administration, and a Doctor of Philosophy (Ph.D.) in Molecular Pharmacology and Cancer Therapeutics from the Roswell Park Cancer Institute.

Professionally, Alicia Henn serves as the Chief Scientific Officer at BioSpherix, showcasing her expertise and leadership in the field.

Her previous roles include Adjunct Assistant Professor at SUNY Upstate Medical University, Senior Associate at the Center for Biodefense Immune Modeling, Founder and President at the Rochester Speculative Literature Association (R-SPEC, Inc.), Postdoctoral Research Associate at the Center for Biodefense Immune Modeling, and Scientist at Vaccinex, Inc.

Alicia Henn's multifaceted background and extensive experience make her a prominent figure driving innovation and positive change in the field of Biomedical Science.